JP2016510596A5 - - Google Patents

Download PDF

Info

Publication number
JP2016510596A5
JP2016510596A5 JP2015561737A JP2015561737A JP2016510596A5 JP 2016510596 A5 JP2016510596 A5 JP 2016510596A5 JP 2015561737 A JP2015561737 A JP 2015561737A JP 2015561737 A JP2015561737 A JP 2015561737A JP 2016510596 A5 JP2016510596 A5 JP 2016510596A5
Authority
JP
Japan
Prior art keywords
fusion protein
seq
acid sequence
amino acid
protein according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015561737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016510596A (ja
JP6576251B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/022052 external-priority patent/WO2014138670A1/en
Publication of JP2016510596A publication Critical patent/JP2016510596A/ja
Publication of JP2016510596A5 publication Critical patent/JP2016510596A5/ja
Application granted granted Critical
Publication of JP6576251B2 publication Critical patent/JP6576251B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015561737A 2013-03-08 2014-03-07 PTD−Smad7薬物療法 Active JP6576251B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361775252P 2013-03-08 2013-03-08
US61/775,252 2013-03-08
PCT/US2014/022052 WO2014138670A1 (en) 2013-03-08 2014-03-07 Ptd-smad7 therapeutics

Publications (3)

Publication Number Publication Date
JP2016510596A JP2016510596A (ja) 2016-04-11
JP2016510596A5 true JP2016510596A5 (enExample) 2017-03-30
JP6576251B2 JP6576251B2 (ja) 2019-09-18

Family

ID=51492023

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015561737A Active JP6576251B2 (ja) 2013-03-08 2014-03-07 PTD−Smad7薬物療法

Country Status (8)

Country Link
US (5) US10456448B2 (enExample)
EP (1) EP2964774B1 (enExample)
JP (1) JP6576251B2 (enExample)
CN (1) CN105358704B (enExample)
CA (1) CA2904329C (enExample)
IL (1) IL241190B (enExample)
SG (1) SG11201507045TA (enExample)
WO (1) WO2014138670A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084746B2 (en) 2010-09-22 2015-07-21 The Regents Of The University Of Colorado, A Body Corporate Therapeutic applications of SMAD7
EP2964774B1 (en) 2013-03-08 2020-05-06 The Regents of The University of Colorado, A Body Corporate Ptd-smad7 therapeutics
KR101853923B1 (ko) * 2016-01-25 2018-05-02 연세대학교 산학협력단 Smad 단백질을 포함하는 자가 면역 질환 치료용 조성물, Smad 단백질을 포함하는 융합 단백질, 이를 제조하기 위한 벡터, 및 이의 제조 방법
CN112004546A (zh) * 2017-12-30 2020-11-27 科罗拉多大学董事会 Ptd-smad7融合蛋白治疗剂
WO2022191244A1 (ja) * 2021-03-10 2022-09-15 国立大学法人熊本大学 コロナウイルス感染を検出する方法
EP4401785A4 (en) * 2021-09-15 2025-11-05 Univ Colorado Regents SMAD7 POLYPEPTIDE FORMULATIONS
US20250269063A2 (en) * 2022-02-07 2025-08-28 Aavogen Inc. Codon-optimized smad7 gene therapy to treat and prevent muscle wasting and to enhance muscle mass

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8200523A (nl) 1982-02-11 1983-09-01 Univ Leiden Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
US4879236A (en) 1984-05-16 1989-11-07 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4952500A (en) 1988-02-01 1990-08-28 University Of Georgia Research Foundation, Inc. Cloning systems for Rhodococcus and related bacteria
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5302523A (en) 1989-06-21 1994-04-12 Zeneca Limited Transformation of plant cells
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5322783A (en) 1989-10-17 1994-06-21 Pioneer Hi-Bred International, Inc. Soybean transformation by microparticle bombardment
ES2091916T3 (es) 1989-12-21 1996-11-16 Whitehead Biomedical Inst Metodo para suministrar moleculas en el interior de celulas eucarioticas.
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5384253A (en) 1990-12-28 1995-01-24 Dekalb Genetics Corporation Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
WO1993004169A1 (en) 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5610042A (en) 1991-10-07 1997-03-11 Ciba-Geigy Corporation Methods for stable transformation of wheat
US5702932A (en) 1992-07-20 1997-12-30 University Of Florida Microinjection methods to transform arthropods with exogenous DNA
CA2140910C (en) 1992-07-27 1999-03-23 Jeffrey A. Townsend An improved method of agrobacterium-mediated transformation of cultured soybean cells
CA2135642C (en) 1992-08-21 1999-12-14 James G. Barsoum Tat-derived transport polypeptides
GB9222888D0 (en) 1992-10-30 1992-12-16 British Tech Group Tomography
US5436222A (en) 1993-03-15 1995-07-25 The Research Foundation Of State University Of New York Use of platelet factor 4 to treat inflammatory diseases
US5656610A (en) 1994-06-21 1997-08-12 University Of Southern California Producing a protein in a mammal by injection of a DNA-sequence into the tongue
US5871986A (en) 1994-09-23 1999-02-16 The General Hospital Corporation Use of a baculovirus to express and exogenous gene in a mammalian cell
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5780448A (en) 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
US5945100A (en) 1996-07-31 1999-08-31 Fbp Corporation Tumor delivery vehicles
US5981274A (en) 1996-09-18 1999-11-09 Tyrrell; D. Lorne J. Recombinant hepatitis virus vectors
GB2320431B (en) * 1996-12-20 2000-08-30 Johnson & Johnson Medical Compositions for the treatment of chronic wounds
EP0983360A1 (en) 1997-05-20 2000-03-08 Ludwig Institute For Cancer Research Smad7 and uses thereof
US6891082B2 (en) 1997-08-01 2005-05-10 The Johns Hopkins University School Of Medicine Transgenic non-human animals expressing a truncated activintype II receptor
US5994624A (en) 1997-10-20 1999-11-30 Cotton Incorporated In planta method for the production of transgenic plants
CA2324476A1 (en) 1998-03-27 1999-10-07 Eli Lilly And Company Treatment and prevention of vascular disease
US8466134B1 (en) 1998-06-26 2013-06-18 Athena Neurosciences, Inc. Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6998240B2 (en) 2001-06-11 2006-02-14 Wisconsin Alumni Research Foundation Screen for selective inhibitors or activators of Smad protein function
AUPR638101A0 (en) 2001-07-13 2001-08-09 Bioa Pty Limited Composition and method for treatment of disease
US7299801B2 (en) 2002-09-06 2007-11-27 3M Innovative Properties Company Metering valve for a metered dose inhaler providing consistent delivery
KR100472938B1 (ko) 2002-10-31 2005-03-11 학교법인 한림대학교 세포침투 효율을 향상시킨 수송도메인-목표단백질-수송도메인 융합단백질 및 그 용도
JP2007508026A (ja) 2003-10-16 2007-04-05 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ Es細胞の自己再生および系統仕様の制御ならびにそのための培地
DK1845942T3 (da) 2005-01-14 2014-04-28 Camurus Ab GNRH-analogformuleringer
CA2605939A1 (en) 2005-04-05 2006-10-12 Pioneer Hi-Bred International, Inc. Methods and compositions for designing nucleic acid molecules for polypeptide expression in plants using plant virus codon-bias
CN104873956B (zh) 2005-09-27 2019-04-23 组织技术公司 羊膜制品和纯化的组合物及其使用方法
WO2008105925A2 (en) 2006-09-01 2008-09-04 Oregon Health & Science University COMPOUNDS AND METHODS FOR MODULATING β-CATENIN/SMAD-7 INTERACTIONS
US20080114287A1 (en) 2006-11-14 2008-05-15 Kar Neng Lai Ultrasound Microbubble Mediated Genes Delivery System
CN102027105B (zh) 2008-03-17 2015-03-11 斯克里普斯研究所 用于产生诱导的多能干细胞的组合化学遗传方法
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
WO2009151600A2 (en) 2008-06-10 2009-12-17 Tufts University Smad proteins control drosha-mediated mirna maturation
US20100184033A1 (en) 2008-07-16 2010-07-22 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
US9084746B2 (en) 2010-09-22 2015-07-21 The Regents Of The University Of Colorado, A Body Corporate Therapeutic applications of SMAD7
WO2013151663A1 (en) * 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of membrane proteins
EP2964774B1 (en) 2013-03-08 2020-05-06 The Regents of The University of Colorado, A Body Corporate Ptd-smad7 therapeutics

Similar Documents

Publication Publication Date Title
JP2016510596A5 (enExample)
Ye et al. TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis
HRP20201973T1 (hr) Ligandi modificirani kružnom permutacijom kao agonisti i antagonisti
JP2012115277A5 (enExample)
JP2013136622A5 (enExample)
CY1122703T1 (el) 1η-πυραζολο[3,4-β]πυριδινες και θεραπευτικες χρησεις αυτων
JPWO2019156137A5 (enExample)
JP2012041342A5 (enExample)
JP2018520646A5 (enExample)
JP2014534202A5 (enExample)
JP2015533791A5 (enExample)
JP2015510393A5 (enExample)
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
JP2017532343A5 (enExample)
JP2014513952A5 (enExample)
JP2015514132A5 (enExample)
JP2017511133A5 (enExample)
BR112016027814A2 (pt) sal de cloreto de tat-nr2b9c
RU2016108808A (ru) Терапевтическое применение vegf-c и ccbe1
IL269187B1 (en) Dominant active yap, a hippo effector, induces chromatin accessiblity and cardiomyocyte renewal
RU2015112625A (ru) Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция
MX389053B (es) Peptidomimeticos de horquilla beta como inhibidores de elastasa selectivos.
JP2019531293A5 (enExample)
JP2013531491A5 (enExample)
JP2014506231A5 (enExample)